Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial.

Autor: Xu, Jie1 (AUTHOR), Wang, Bai-Yan2 (AUTHOR), Yu, Shan-He1 (AUTHOR), Chen, Shi-Jun1 (AUTHOR), Yang, Shuang-Shuang1 (AUTHOR), Liu, Rui2 (AUTHOR), Chen, Li-Juan3 (AUTHOR), Hou, Jian4 (AUTHOR), Chen, Zhu1 (AUTHOR), Zhao, Wan-Hong2 (AUTHOR) 13991365406@163.com, He, Ai-Li2 (AUTHOR) heaili@xjtu.edu.cn, Mi, Jian-Qing1 (AUTHOR) jianqingmi@shsmu.edu.cn, Chen, Sai-Juan1 (AUTHOR) sjchen@stn.sh.cn
Zdroj: Journal of Hematology & Oncology. 4/24/2024, Vol. 17, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje